Alankit Ltd approves ₹43 crore warrant allotment to promoter
- Alankit Limited approved the allotment of 5 crore fully convertible warrants
- The warrants are issued at ₹8.60 each to promoter Alka Agarwal
- Total fundraising from the preferential allotment stands at ₹43 crore
- Fully diluted equity share capital will be ₹32.11 crore post-allotment

*this image is generated using AI for illustrative purposes only.
Alankit Limited has approved the preferential allotment of 5 crore fully convertible warrants to its promoter, Alka Agarwal, for an aggregate amount of ₹43 crore. The allotment price is fixed at ₹8.60 per warrant.
The decision was taken by the Management Committee of the Board of Directors during a meeting held on October 5, 2026. The warrants are being issued on a preferential basis to a member of the Promoter & Promoter Group category.
Allotment Details
The company disclosed that the total issue size amounts to ₹43,00,00,000 (₹43 crore). The following table outlines the specific allocation details:
| Parameter | Detail |
|---|---|
| Allottee | Alka Agarwal |
| Category | Promoter Group |
| Number of Warrants | 5,00,00,000 |
| Issue Price | ₹8.60 per warrant |
| Total Amount | ₹43 crore |
Capital Structure Impact
Consequent to this allotment, the paid-up equity share capital of the company on a fully diluted basis will stand at ₹32,11,58,100. This capital is divided into 32,11,58,100 equity shares with a face value of ₹1 each.
The Management Committee meeting commenced at 5:00 pm and concluded at 5:30 pm. The company informed both BSE Limited and National Stock Exchange of India Limited regarding the outcome of the meeting in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Alankit
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.52% | -3.79% | -5.70% | +5.84% | -41.37% | -57.25% |
How will the ₹43 crore capital infusion specifically be deployed to drive Alankit Limited's future growth initiatives?
What is the timeline for the conversion of these warrants into equity, and how might this dilution impact existing minority shareholders?
Does the preferential allotment to the promoter signal a strategic shift in ownership structure or potential consolidation within the Promoter Group?


































